menu
    • menu

    Company profile for Cordis

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    During our 60-year history we’ve established a legacy of pioneering breakthrough technologies, including the first guiding catheters and coronary drug eluting stents. Cordis has built a strong global footprint that spans 70 countries. We remain committed to saving millions of lives through innovation, clinical acumen, training, and service. Our mission is to delight customers by developing differentiated solutions at pace t...
    During our 60-year history we’ve established a legacy of pioneering breakthrough technologies, including the first guiding catheters and coronary drug eluting stents. Cordis has built a strong global footprint that spans 70 countries. We remain committed to saving millions of lives through innovation, clinical acumen, training, and service. Our mission is to delight customers by developing differentiated solutions at pace that improve patient vitality and help lower the cost of care.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CordisAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    Level 14/3 Parramatta Square 154 Macquarie Street, Parramatta NSW, 2150
    Telephone
    Telephone
    (+61) 1800 077 421
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cordis.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tevogen Signs Intent for New In-House Cell Therapy Manufacturing
    Tevogen Signs Intent for New In-House Cell Therapy Manufacturing

    17 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/17/3117301/0/en/Tevogen-Signs-Letter-of-Intent-for-New-In-House-Cell-Therapy-Manufacturing-Facility.html

    GLOBENEWSWIRE
    17 Jul 2025
    Share Share
    Cordis Launches 10,000-Patient Global Coronary Registry for SELUT
    Cordis Launches 10,000-Patient Global Coronary Registry for SELUT

    19 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cordis-launches-10-000-patient-global-coronary-registry-for-selution-slr-drug-eluting-balloon-302458167.html

    PR NEWSWIRE
    19 May 2025
    Share Share
    Cordis: SELUTION SLR Balloon Shows Durable Efficacy in PAD Studies
    Cordis: SELUTION SLR Balloon Shows Durable Efficacy in PAD Studies

    24 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cordis-announces-positive-results-from-two-major-studies-demonstrating-durable-efficacy-of-selution-slr-drug-eluting-balloon-in-complex-peripheral-artery-disease-patients-302437748.html

    PR NEWSWIRE
    24 Apr 2025
    Share Share
    Cordis Announces 24-Month Results Confirming Benefits Of SELUTION
    Cordis Announces 24-Month Results Confirming Benefits Of SELUTION

    18 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cordis-announces-positive-24-month-results-from-superficial-femoral-artery-study-confirming-sustained-benefits-of-selution-slr-sustained-limus-release-drug-eluting-balloon-in-complex-patients-302174924.html

    PR NEWSWIRE
    18 Jun 2024
    Share Share
    MedAlliance acquired by Cordis for $1.13 billion
    MedAlliance acquired by Cordis for $1.13 billion

    17 Nov 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/medalliance-acquired-by-cordis-for-1-13-billion/articleshow/105311536.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    17 Nov 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search